EI
BSX icon

Ellevest Inc’s Boston Scientific BSX Stock Holding History

Ellevest Inc’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$758K Buy
12,086
+1,261
+12% +$101K 0.11% 139
2025
Q4 		$1.03M Sell
10,825
-462
-4% -$45.3K 0.14% 93
2025
Q3 		$1.1M Sell
11,287
-2,442
-18% -$253K 0.16% 96
2025
Q2 		$1.47M Sell
13,729
-979
-7% -$99.1K 0.24% 62
2025
Q1 		$1.48M Buy
14,708
+785
+6% +$79K 0.1% 71
2024
Q4 		$1.24M Buy
13,923
+650
+5% +$57.2K 0.07% 90
2024
Q3 		$1.11M Buy
13,273
+371
+3% +$29.2K 0.06% 99
2024
Q2 		$994K Buy
12,902
+888
+7% +$65K 0.06% 99
2024
Q1 		$823K Buy
12,014
+149
+1% +$9.58K 0.05% 124
2023
Q4 		$686K Buy
11,865
+145
+1% +$7.74K 0.05% 132
2023
Q3 		$619K Buy
11,720
+641
+6% +$33.6K 0.05% 124
2023
Q2 		$599K Buy
11,079
+683
+7% +$35.7K 0.05% 121
2023
Q1 		$520K Buy
10,396
+1,432
+16% +$67.5K 0.04% 128
2022
Q4 		$415K Buy
8,964
+1,467
+20% +$63.5K 0.03% 162
2022
Q3 		$290K Sell
7,497
-1,380
-16% -$55.4K 0.03% 189
2022
Q2 		$331K Buy
8,877
+2,042
+30% +$83.1K 0.03% 177
2022
Q1 		$303K Buy
6,835
+438
+7% +$19K 0.03% 234
2021
Q4 		$272K Sell
6,397
-30
-0.5% -$1.26K 0.02% 233
2021
Q3 		$279K Buy
6,427
+2,199
+52% +$97.3K 0.03% 206
2021
Q2 		$181K Buy
4,228
+1,473
+53% +$62K 0.02% 277
2021
Q1 		$106K Buy
2,755
+444
+19% +$16.8K 0.01% 331
2020
Q4 		$83K Sell
2,311
-765
-25% -$27.6K 0.01% 351
2020
Q3 		$118K Buy
3,076
+1,015
+49% +$39.1K 0.02% 214
2020
Q2 		$72K Buy
2,061
+1,043
+102% +$37.6K 0.02% 296
2020
Q1 		$33K Buy
1,018
+575
+130% +$22.5K 0.01% 316
2019
Q4 		$20K Buy
443
+268
+153% +$11.2K 0.01% 412
2019
Q3 		$7K Buy
175
+45
+35% +$1.91K ﹤0.01% 247
2019
Q2 		$6K Buy
130
+53
+69% +$2.04K ﹤0.01% 281
2019
Q1 		$3K Sell
77
-84
-52% -$3.21K ﹤0.01% 261
2018
Q4 		$6K Buy
+161
New +$5.84K ﹤0.01% 407

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ellevest Inc's BSX Position: Q1 2026 in Review

Ellevest Inc increased its Boston Scientific (BSX) stake by 12% in Q1 2026, buying an estimated $101K and bringing the position to 12,086 shares worth $758K. The position accounts for 0.11% of the portfolio, ranked #139.

Ellevest Inc first reported a position in BSX in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.48M in Q1 2025. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ellevest Inc held 12,086 shares of Boston Scientific worth $758K as of Q1 2026.
  • Ellevest Inc bought 1,261 Boston Scientific shares in Q1 2026, an estimated $101K.
  • Boston Scientific made up 0.11% of Ellevest Inc's portfolio in Q1 2026, its #139 holding.
  • Ellevest Inc first reported a position in Boston Scientific in Q4 2018 and has held it in 30 quarters since.
  • Ellevest Inc's Boston Scientific position peaked at $1.48M in Q1 2025.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.